Escucha el podcast Out of the Blue: An AJRCCM Podcast

Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography and Rethinking the Computed Tomography and Histopathological Nomenclature of Hypersensitivity Pneumonit	Out of the Blue: An AJRCCM Podcast	33:24
Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)	Out of the Blue: An AJRCCM Podcast	35:19
Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis and Progress in Progressive Pulmonary Fibrosis	Out of the Blue: An AJRCCM Podcast	21:24
A New Global Definition of Acute Respiratory Distress Syndrome	Out of the Blue: An AJRCCM Podcast	33:36
Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease	Out of the Blue: An AJRCCM Podcast	21:32
Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease	Out of the Blue: An AJRCCM Podcast	46:17
Approach to the Evaluation and Management of Interstitial Lung Abnormalities	Out of the Blue: An AJRCCM Podcast	30:28
Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE)" and "Camlipixant: A New Hope for Refractory Chronic Cough?	Out of the Blue: An AJRCCM Podcast	28:51
Dexmedetomidine and Propofol Sedation in Critically Ill Patients and Dose Associated 90-day Mortality: A Secondary Cohort Analysis of a Randomized Controlled Trial (SPICE-III)	Out of the Blue: An AJRCCM Podcast	33:55
Early vs. Delayed Switching from Controlled to Assisted Ventilation: A Target Trial Emulation	Out of the Blue: An AJRCCM Podcast	24:51
A New Global Definition of Acute Respiratory Distress Syndrome	Out of the Blue: An AJRCCM Podcast	33:36
Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease	Out of the Blue: An AJRCCM Podcast	46:19
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline	Out of the Blue: An AJRCCM Podcast	16:39
Using Isoniazid More Safely and More Effectively in Tuberculosis Treatment	Out of the Blue: An AJRCCM Podcast	35:16
A Randomized Controlled Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea	Out of the Blue: An AJRCCM Podcast	24:33
Progressive Early Interstitial Lung Abnormalities in Persons At-Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study and Big Things Have Small Beginnings: Clinical Implications of Early In	Out of the Blue: An AJRCCM Podcast	27:14
Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research Statement	Out of the Blue: An AJRCCM Podcast	24:13
Hypnotics on Obstructive Sleep Apnea Severity and Endotypes: A Systematic Review and Meta-Analysis and The Arousal Threshold: The ‘Weakest Link’ in OSA Pathogenesis?	Out of the Blue: An AJRCCM Podcast	37:57
Evaluation of Etomidate Use and Association with Mortality Compared with Ketamine among Critically Ill Patients	Out of the Blue: An AJRCCM Podcast	33:45
From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICU	Out of the Blue: An AJRCCM Podcast	27:47
Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease	Out of the Blue: An AJRCCM Podcast	21:32
Senolytic-facilitated Reversal of End-Organ Dysfunction in a Murine Model of Obstructive Sleep Apnea	Out of the Blue: An AJRCCM Podcast	32:44
Effectiveness of Fludrocortisone Plus Hydrocortisone Versus Hydrocortisone Alone in Septic Shock: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials	Out of the Blue: An AJRCCM Podcast	20:49
Inhalable Textile Microplastic Fibers Impair Airway Epithelial Differentiation and Inhaled Microplastics and Airway Development: Concerning Evidence from Organoids	Out of the Blue: An AJRCCM Podcast	25:59
A New Global Definition of Acute Respiratory Distress Syndrome	Out of the Blue: An AJRCCM Podcast	33:05
External Control Arms in Idiopathic Pulmonary Fibrosis Using Clinical Trial and Real-World Data Sources and The Added Power of Synthetic Control Groups: Challenging Conventional Wisdom and Trial Desig	Out of the Blue: An AJRCCM Podcast	32:50
The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial and Pharmacologic Therapy for Obstructive Sleep Apnea: Are We Seei	Out of the Blue: An AJRCCM Podcast	22:43
FEV1/FVC Severity Stages for Chronic Obstructive Pulmonary Disease	Out of the Blue: An AJRCCM Podcast	16:21
Conservative versus Liberal Oxygenation Targets in Intensive Care Unit Patients (ICONIC): A Randomized Clinical Trial	Out of the Blue: An AJRCCM Podcast	17:14
Pulse Wave Amplitude Drops Index: A Biomarker of Cardiovascular Risk in Obstructive Sleep Apnea	Out of the Blue: An AJRCCM Podcast	20:38
Individualized Treatment Effects of Bougie vs Stylet for Tracheal Intubation in Critical Illness	Out of the Blue: An AJRCCM Podcast	25:09
Effectiveness of Bedaquiline Use Beyond Six Months in Patients with Multidrug-Resistant Tuberculosis	Out of the Blue: An AJRCCM Podcast	22:10
Dexmedetomidine and Propofol Sedation in Critically Ill Patients and Dose Associated 90-day Mortality: A Secondary Cohort Analysis of a Randomized Controlled Trial (SPICE-III)	Out of the Blue: An AJRCCM Podcast	33:19
Tuberculosis Diagnoses Following Wildfire Smoke Exposure in California	Out of the Blue: An AJRCCM Podcast	17:48
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results	Out of the Blue: An AJRCCM Podcast	14:59
Cardiovascular Benefit of Continuous Positive Airway Pressure in Adults with Coronary Artery Disease and Obstructive Sleep Apnea without Excessive Sleepiness	Out of the Blue: An AJRCCM Podcast	24:03
High-Flow Versus VenturiMask Oxygen Therapy to Prevent Re-Intubation in Hypoxemic Patients After Extubation: A Multicenter, Randomized Clinical Trial	Out of the Blue: An AJRCCM Podcast	28:24
Autoimmune Pulmonary Alveolar Proteinosis	Out of the Blue: An AJRCCM Podcast	21:47
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome Associated with COVID-19: An Emulated Target Trial Analysis	Out of the Blue: An AJRCCM Podcast	27:31
Coarse Particulate Air Pollution and Daily Mortality: A Global Study in 205 Cities	Out of the Blue: An AJRCCM Podcast	25:55

Outcomes of a Typical Fibrotic Hypersensitivity Pneumonitis Pattern on Chest Computed Tomography and Rethinking the Computed Tomography and Histopathological Nomenclature of Hypersensitivity Pneumonit

Out of the Blue: An AJRCCM Podcast

33:24

Temporary Transvenous Diaphragm Neurostimulation for Weaning from Mechanical Ventilation (RESCUE-3)

Out of the Blue: An AJRCCM Podcast

35:19

Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis and Progress in Progressive Pulmonary Fibrosis

Out of the Blue: An AJRCCM Podcast

21:24

A New Global Definition of Acute Respiratory Distress Syndrome

Out of the Blue: An AJRCCM Podcast

33:36